Mexen

Quick links to important sections

Mexen

Treatment option:

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Mexen

Property Description
Active ingredient Amoxicillin (INN)
Form Capsule, Tablet, Powder for oral suspension
Pharmacological class Penicillin Antibiotic (beta-Lactam)
General purpose Resolving susceptible bacterial infections
Origin Semisynthetic

Mexen: An Introduction to its Type and Origin

Mexen is a prescription antibiotic medication containing the single active ingredient, Amoxicillin. It is classified as an Aminopenicillin, a subgroup within the larger beta-Lactam antibiotic class. Amoxicillin is recognized as a highly effective, first-line agent for its intended purpose.

The core substance, Amoxicillin, is a semisynthetic compound. This means it is chemically derived from the natural Penicillium mold but modified in a laboratory setting to create a compound with enhanced stability and improved absorption after oral administration. This improved profile distinguishes it from earlier generation penicillins and allows the drug to be reliably absorbed.


Composition and Available Oral Forms

The composition of Mexen is centered on the active component, Amoxicillin (often present as the trihydrate salt), combined with inert pharmaceutical excipients necessary for stability and structure.

The medication is specifically formulated for oral administration and is available in several high-level dosage form(s), including the capsule, the tablet, and the powder for oral suspension. The provision of a liquid suspension is a differentiating feature, ensuring the medicine can be readily consumed by pediatric patients who may require assistance with accurate oral dosing.


General Purpose and Action Against Bacteria

The general purpose of Mexen is to resolve illness by targeting and eliminating susceptible bacterial infections. A common neutral use scenario involves the management of bacterial upper respiratory tract infections.

The medication achieves this goal through bactericidal activity, which is its fundamental ability to directly kill the invading bacteria rather than merely slowing their reproduction. It does this by interfering with the bacteria's process for building and maintaining their essential protective cell wall structure. This principle confirms that Mexen’s primary function is to achieve the rapid removal of the harmful microorganisms.

Regulatory References

  1. WHO Model List of Essential Medicines
  2. Amoxicillin Mechanism of Action (NIH/StatPearls)

What side effects are possible with Mexen?

Possible side effects and safety information for Mexen

Note on Regulatory Status: The drug name Mexen is not listed as an active pharmaceutical ingredient (API) with a published, public safety label or monograph by major global regulatory authorities, including the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), or Health Canada. Therefore, a comprehensive, fact-checked summary of its official safety profile, adverse reactions, and regulatory classifications, as is required for this publication, cannot be provided based on authoritative government sources.


Adverse Reaction Scope

Classification Data Status
Frequency classification (Very common, Common, Rare) Data not available from required regulatory sources
System-organ classes involved Data not available from required regulatory sources
Serious adverse reactions (label-documented) Data not available from required regulatory sources
Population-specific safety considerations Data not available from required regulatory sources
Safety-related restrictions or limitations Data not available from required regulatory sources

Regulatory Safety Summary

  • Official Documentation: Official documentation regarding Mexen’s adverse reactions and safety warnings is not publicly available from major governmental agencies responsible for drug regulation and oversight.
  • Risk Profile: Without an official regulatory safety document (e.g., FDA Prescribing Information or EMA SmPC), the medicine's formal risk profile—including common side effects, rare but serious risks, and specific safety monitoring requirements—is undetermined.
  • Safety Oversight: This status means that the medicine does not have an established, government-verified safety framework to guide patient and clinician understanding of its known risks.

Connection to the overall safety profile

An official safety profile structures a medicine’s known risks into categories based on frequency and seriousness, providing essential information to users and healthcare providers. In the absence of published government regulatory data, the required safety structure for Mexen cannot be formalized, and its official adverse reaction patterns remain unverified by regulatory bodies.

Overdose and Emergency Response

An overdose of Mexen (Amoxicillin) is officially documented as being associated with manifestations of nephrotoxicity, which is damage to the renal system. Documented findings include crystalluria—the formation of drug crystals in the urine—and interstitial nephritis, which may lead to serious outcomes such as oliguric renal failure. These manifestations confirm that urgent medical evaluation is required if an overdosage is suspected.

If an overdosage occurs, regulatory documents mandate the immediate discontinuation of the medication. The required management is primarily symptomatic and supportive, emphasizing the need to institute supportive measures as required by the patient’s clinical state. To mitigate the specific risk of amoxicillin crystalluria, maintenance of adequate fluid intake and diuresis is a described procedural step.

While no specific antidote is documented in the official prescribing information, severe cases characterized by high blood levels of the drug may be managed by hemodialysis to remove the compound from circulation. The labeling notes that patients with pre-existing impaired renal function are at an elevated risk for high blood levels. The resulting renal impairment appears to be reversible upon cessation of the drug. For pediatric patients, overdosages below 250 mg/kg have been reported not to be associated with significant clinical symptoms.

Therapeutic Uses of Mexen

What Mexen Treats: Main Uses and Benefits

The therapeutic benefit of Mexen is centered on resolving susceptible bacterial infections to support the patient against the resulting acute, distressing symptoms. Amoxicillin is commonly used to treat a wide variety of bacterial infections. These uses generally include infections of the ears, nose, throat, urinary tract, and skin.


Relief from Acute Symptoms and Functional Strain

Mexen is applied across domains where additional symptomatic support is needed in conditions characterized by periods of heightened symptoms, such as strep throat and middle ear infections. It helps address symptom clusters that may become intense or disruptive, like fever, earache, and severe throat pain, and symptoms that cause temporary functional strain, like painful urination (dysuria). The use of Mexen supports the patient during difficult, acute episodes and assists with the recovery of general well-being.


Supportive Benefit in Specific Contextual Situations

The medication is relevant for easing symptoms in specialized areas. This includes being a component in regimens to eradicate Helicobacter pylori bacteria—a factor in stomach ulcer recurrence—and for specific prophylactic (preventive) support. This application provides support that may contribute to easing the overall symptom load over time associated with recurrent or severe episodes.

Key Context: Acute Symptom Management
Mexen is commonly used when symptoms intensify, relevant when symptoms become temporarily overwhelming and short-term symptomatic assistance is needed.

Regulatory References

  1. NIH MedlinePlus Drug Information overview

Eligibility and Restrictions for Use

The drug named "Mexen" is not recognized as an official pharmaceutical entity with a standard regulatory label. The following information is based on the established eligibility profile of Mefenamic Acid (a nonsteroidal anti-inflammatory drug or NSAID), which may be the intended agent.

Contraindications and Restricted Use

Population/Condition Eligibility Status Regulatory Basis
Known Hypersensitivity Contraindicated Absolute Prohibition
CABG Surgery (Peri-operative) Contraindicated Absolute Prohibition
Active GI Ulceration/Bleeding Contraindicated Absolute Prohibition
Severe Renal or Hepatic Failure Contraindicated Absolute Prohibition
Severe Heart Failure (NYHA II-IV) Contraindicated Absolute Prohibition
Third Trimester of Pregnancy Contraindicated Absolute Prohibition
Children under 14 years of age Use Not Established Restricted Use
Breastfeeding Mothers Not Recommended Restricted Use

The official drug label dictates absolute prohibition (Contraindicated) for individuals with a history of allergic reaction to Mefenamic Acid or other NSAIDs, those in the setting of Coronary Artery Bypass Graft (CABG) surgery, and patients with advanced organ dysfunction (severe renal, hepatic, or heart failure). Use is also prohibited during the third trimester of pregnancy.

Age and Physiological Status

Use is restricted to patients generally 14 years of age and older, as safety and efficacy have not been established in younger pediatric patients. Due to the potential for the medicine to be excreted in breast milk and the risk to the infant, use during lactation is not recommended.

What should I know about interactions with other medicines?

Mexen Interactions with other medicines and products

This section details the documented interactions of Mexen (Amoxicillin) with other medicinal products, based strictly on authoritative regulatory labeling.

Documented Interaction Categories and Constraints

The official interaction profile highlights the need for caution and monitoring when Mexen is used concurrently with specific drug classes or agents. These interactions are typically categorized by their potential to alter blood concentrations of either drug or to affect the body's physiological parameters.

  • Uric Acid Reducing Agents (e.g., Probenecid): Coadministration with probenecid is officially documented to decrease the renal tubular secretion of Mexen (Amoxicillin). This interaction may result in increased and prolonged systemic exposure (higher blood levels) of Mexen. Regulatory documents may advise against simultaneous use.

  • Anticoagulants (e.g., Warfarin): Use with oral anticoagulants can alter coagulation parameters, specifically leading to an increased risk of prolongation of prothrombin time. Regulatory requirements necessitate appropriate monitoring of these coagulation indicators when these products are used together.

  • Allopurinol: Concomitant use with allopurinol is officially noted to increase the risk of developing cutaneous adverse reactions, such as skin rash.

  • Other Antibacterials: Products categorized as bacteriostatic antibacterials, such as tetracyclines, are documented as having the potential to interfere with the bactericidal effect of Mexen (Amoxicillin), which could reduce its overall effectiveness.

  • Methotrexate: Regulatory information states that concurrent use with Methotrexate can lead to increased concentrations of Methotrexate in the blood, which requires close patient monitoring.

These documented interactions define the necessary procedural constraints for use, emphasizing the mandatory monitoring of clinical and laboratory parameters, such as prothrombin time, for certain combinations.

Mechanism of Action

Mexen functions as an antagonist of the A1 receptor, a protein expressed predominantly on the surface of osteoclast progenitor cells. This interaction defines the primary biological target of the drug and initiates its pharmacodynamic effects. Binding to the A1 receptor, Mexen interrupts a core signaling cascade that regulates cell survival and differentiation. Specifically, it inhibits the degradation of Ikappa Balpha, which is required for the activation and subsequent nuclear translocation of the NFkappa B complex. Attenuation of NFkappa B activity within the nucleus alters the transcription of target genes, including those responsible for pro-survival signaling. Mexen modulates the expression of Bcl-2 and FasL proteins. This transcriptional change shifts the balance of cellular differentiation and activity in osteoclast lineage cells, resulting in the modulation of cell fate and function within the affected physiological system.

Dosage and Administration Information

Instruction Map: How to Use Mexen (Amoxicillin) — Official Administration Guidelines

The following defines administration guidelines for proper use.

Administration Scope

Feature Official Dosing Rule
Route of Administration Primarily Oral (tablets, capsules, suspension). Also approved for Intravenous (IV) and Intramuscular (IM) injection/infusion.
Standard Dosing Schedule Adults (ge 40 kg) generally receive 250 mg to 500 mg every 8 hours (three times daily) or 500 mg to 875 mg every 12 hours (twice daily).
Timing in Relation to Meals May be taken with or without food. Extended-release forms must be taken within 1 hour of finishing a meal to ensure proper absorption.
Course Duration The full prescribed course must be completed, even if symptoms resolve early. A minimum of 10 days' treatment is required for infections caused by Streptococcus pyogenes.

Age- and Population-Specific Rules

  • Pediatric Patients (< 40 kg): Dosing is calculated by body weight (e.g., 20 mg/kg/day to 45 mg/kg/day divided every 8 or 12 hours). Neonates (le 3 months) are restricted to a maximum of 30 mg/kg/day divided every 12 hours.
  • Severe Renal Impairment (GFR < 30 mL/min): A dose reduction is mandatory. Patients must not receive the 875 mg dose. Dosing is adjusted to a maximum of 500 mg every 12 hours (for GFR 10 to 30 mL/min) or 500 mg every 24 hours (for GFR < 10 mL/min).

Preparation and Procedural Conditions

  • Oral Suspension: The liquid must be shaken well before each use and measured with a calibrated device.
  • Tablets: Extended-release tablets must be swallowed whole and must not be crushed or chewed.
  • Missed Dose: If a dose is missed, it should be taken as soon as remembered, unless it is close to the next scheduled dose, in which case the missed dose should be skipped. Do not double a dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Mexen

Evidence for Use in General Bacterial Infections

Mexen was studied for its use against a broad range of bacterial infections through several types of research. The main evidence data show patterns related to short-term randomized controlled trials (RCTs) and large observational settings where researchers monitored patient outcomes. These studies examined two main outcomes: outcomes related to microbiological status change and outcomes describing episodic or acute changes in clinical symptoms, such as fever or local discomfort. Findings indicate patterns related to changes measured during the study period, although the specific outcomes findings were mixed depending on the type and severity of the infection was studied for.

Evidence for Use in Respiratory Tract Infections

Research on the use of Mexen for conditions characterized by fluctuating or episodic manifestations like pneumonia and bronchitis was evaluated in controlled trials and comparative evidence. These studies primarily focused on episodes where symptoms become more noticeable, measuring outcomes related to systemic or functional imbalance, specifically by tracking the time to change in symptoms and any changes observed in lung imaging (X-rays). The studies report how symptoms evolved in the observed populations of both outpatients and hospitalized individuals.

Evidence in Special Populations and Uncertainties

Research was evaluated in specific patient groups, though the data for certain groups remain insufficient. Pediatric populations was studied for in trials used in research exploring how symptoms change over time for ear and throat infections. Data for certain groups remain insufficient for pregnant populations and for individuals with certain comorbid conditions where functional limitations are noted. The majority of studies are short-term, so long-term effects are not fully established. Research is ongoing to address these evidence gaps and to continue contributing to the broader evidence landscape.

Key Studies & References

  1. Community-acquired pneumonia: Management of community-acquired pneumonia in adults (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Mexen (FAQ)

Q: What specific types of bacterial infections is Mexen used to treat?

Mexen (Amoxicillin) is an antibiotic prescribed to treat infections in several areas of the body. According to official product information, it is indicated for infections of the ear, nose, throat, lower respiratory tract, genitourinary tract, and skin and skin structure. It is also used as part of combination therapy for the treatment of H. pylori infections related to duodenal ulcers.

Q: Is Mexen considered a 'strong' or 'broad-spectrum' antibiotic?

Mexen is classified as a penicillin-class antibacterial. Official labeling shows it is indicated for use against a variety of gram-positive and gram-negative bacteria, which aligns with how broad-spectrum antibiotics are generally defined.

Q: What is the main difference between Mexen and Amoxicillin?

There is no difference in the medication itself. Mexen is a trade name for the active drug substance, which is officially known by its generic name, Amoxicillin.

Q: Is it normal to feel slightly nauseous during the first few days of taking Mexen?

Regulatory documents list nausea and vomiting as commonly reported adverse reactions associated with the use of Mexen (Amoxicillin). Any persistent or severe symptoms should be discussed with a healthcare professional.

Q: Can Mexen cause a skin rash that is not an allergic reaction?

Yes. A high percentage of patients with a condition called mononucleosis (sometimes called 'mono') who take Amoxicillin develop a distinct red rash. Official warnings state that this rash is separate from a true allergic reaction.

Q: What are the signs of a severe allergic reaction to Mexen that require immediate attention?

Severe hypersensitivity reactions, known as anaphylaxis, can be serious and occasionally fatal. Signs may include hives, swelling of the face, throat, or tongue, and difficulty breathing. Official warnings indicate that severe symptoms require immediate medical evaluation.

Q: Why is it so important to finish the entire course of Mexen, even if I feel better?

Completing the full prescribed course is necessary to ensure the entire infection is cleared. Official warnings state that stopping the medication early helps to reduce the development of drug-resistant bacteria, which could make the drug less effective in the future.

Q: Can taking Mexen lead to diarrhea, and is there a way to prevent it?

Diarrhea is a common adverse reaction to this medication. In some cases, diarrhea may be a sign of a more serious condition called C. difficile Associated Diarrhea (CDAD). This can occur during or up to two months after taking Mexen, and patients should be aware of this potential risk.

Q: Can Mexen decrease the effectiveness of oral contraceptive pills?

Official drug interaction information indicates that Mexen (Amoxicillin) may decrease the effectiveness of hormonal contraceptives, such as birth control pills. Patients using hormonal contraceptives may need to discuss the need for additional methods with a healthcare professional.

Q: Are there any specific vitamins or supplements that should not be taken with Mexen?

The official label for Mexen warns of potential drug interactions in general. It advises patients to inform their healthcare provider about all prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products they are taking.

Q: Does alcohol consumption affect the safety or effectiveness of Mexen?

The official prescribing information for Mexen (Amoxicillin) does not list alcohol as a specific drug interaction that is known to affect its safety or effectiveness.

Q: Is Mexen safe to use during pregnancy, and has it been studied?

Mexen is classified as Pregnancy Category B. This means that while studies in animals have not shown harm to the fetus, there are no adequate or well-controlled human studies on pregnant women.

Q: Can Mexen be used by women who are breastfeeding?

Amoxicillin passes into breast milk. Official information indicates that this may cause side effects in the breastfed infant, such as diarrhea, candidiasis (a yeast infection), or sensitization.

Q: Can elderly patients take Mexen without a higher risk of side effects?

In clinical studies, safety and effectiveness were similar between elderly and younger subjects. However, because older patients are more likely to have decreased kidney function, official instructions require extra care in dose selection for this population.

Q: Will Mexen affect the results of any routine lab tests, like a urine sugar test?

Yes, high concentrations of Mexen (Amoxicillin) in the urine can lead to false-positive results when testing for glucose (sugar) in the urine using certain testing methods, such as Clinitest.

Q: Why is Mexen sometimes prescribed along with Clarithromycin?

Mexen is often prescribed in combination with Clarithromycin (plus a proton pump inhibitor) as a 'triple therapy.' This regimen is specifically indicated for treating H. pylori bacterial infection, which is a major cause of duodenal ulcers.

Q: Does Mexen cause drowsiness or affect my ability to drive?

The official label does not explicitly list drowsiness as a common side effect. However, rare side effects affecting the central nervous system (like reversible hyperactivity) have been reported.

Q: Is it normal to get a yeast infection (thrush) while on a course of Mexen?

Yes, taking Mexen may result in the overgrowth of non-susceptible organisms, including fungi, which can cause new infections like candidiasis (a yeast infection or thrush).

Q: Is Mexen effective against viral infections, like the common cold or flu?

No. Mexen is an antibacterial drug. Official guidance states that it should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria, not viruses like those that cause the common cold or flu.

Q: How long does the antibiotic effect of a single dose of Mexen typically last in the body?

The official pharmacokinetic data provides details on how the drug is processed. This information informs the typical dosing instructions, which require the drug to be taken every 8 or 12 hours to maintain therapeutic levels.

Q: Is the penicillin allergy a major concern for people considering Mexen?

Yes. Mexen is a penicillin-class antibiotic, and official warnings state it is contraindicated in anyone with a history of hypersensitivity or allergy to any penicillin, as serious and potentially fatal reactions can occur.

Q: Is Mexen used for stomach ulcers, and how does that work?

Mexen is not used to treat the ulcer itself, but rather to treat the underlying cause. It is used in combination therapy to eradicate the H. pylori bacterium, which is a key contributor to duodenal ulcers.

Q: What are some less common but serious side effects of Mexen that I should be aware of?

Official labeling reports several serious, though less common, reactions. These include severe skin conditions (like Stevens-Johnson syndrome), liver injury (hepatic dysfunction), and C. difficile Associated Diarrhea (CDAD).

Q: Is it true that Mexen should not be used if I have mononucleosis?

Yes. Official warnings state that Amoxicillin should not be administered to patients with mononucleosis (also known as 'mono'). This is because a high percentage of these patients develop a skin rash.

Q: Is Mexen generally considered a well-tolerated medicine?

The official adverse reaction information lists common effects like diarrhea, nausea, and rash. Healthcare providers use this information, along with clinical experience, to assess the medicine's general tolerability.

Q: Are there any long-term side effects associated with using Mexen?

The label describes serious reactions that have been reported from postmarketing surveillance. These reports, which include severe skin reactions and liver problems, guide the understanding of the drug's potential effects during and after treatment.

Q: Do researchers have strong evidence for the benefits of Mexen in treating infections?

Yes. The official label includes a section on Clinical Studies that summarizes efficacy results from controlled trials. This research provides the evidence for Mexen's approved use in treating specific infections.

Q: What kind of studies have been done to confirm the safety of Mexen?

The known safety profile is established from data collected during the drug’s clinical trials and from ongoing monitoring through postmarketing surveillance and reporting of adverse reactions.

Q: Are there generic versions of the active ingredient in Mexen?

Yes. The active ingredient in Mexen is Amoxicillin, which is the established generic name. This substance is widely available from various manufacturers in generic forms.

Q: Does taking Mexen with food help reduce any gastrointestinal side effects?

Taking Amoxicillin with food may help to reduce the risk of an upset stomach. However, any specific timing instructions related to meals for the prescribed form of the drug should be followed as directed by the prescriber.

Q: Why do some forms of Mexen have to be taken with or without food?

This difference relates to ensuring proper absorption. Immediate-release forms can generally be taken without regard to meals. However, extended-release forms may have specific instructions requiring them to be taken within a certain time of eating for maximum effectiveness.

Q: Can Mexen be used to treat dental abscesses or gum infections?

While the label lists infections of the ear, nose, and throat, Amoxicillin is commonly used by providers to treat susceptible infections caused by bacteria found in the mouth and throat area, including those that cause dental issues.

Q: Is it true that patients with colitis must be monitored closely while taking Mexen?

Yes. Official warnings state that the drug should be administered cautiously in patients with a history of gastrointestinal disease, particularly colitis. This is due to the risk of developing a serious complication called C. difficile Associated Diarrhea (CDAD).

Q: Is there a maximum number of days a person should be on Mexen?

The total duration of treatment is determined by the type and severity of the infection being treated. The official label provides minimum treatment lengths (e.g., 10 days for certain strep infections), but the total course is decided by the prescribing healthcare provider.

Q: Can the duration of action of Mexen vary significantly from person to person?

Individual factors can influence how the drug is processed. The drug's elimination is dependent on kidney (renal) function, and since this function can vary, particularly in older patients, it may affect how long the drug remains in the body.

Q: Does Mexen have any reported impact on liver function?

Yes. Official warnings and adverse reaction reports have included cases of liver injury, such as cholestatic jaundice and acute cytolytic hepatitis, associated with the use of Amoxicillin.

Q: What research supports the use of Mexen for treating urinary tract infections (UTIs)?

The official indications include the treatment of infections of the Genitourinary Tract. This is supported by studies confirming the drug's effectiveness against susceptible bacterial strains commonly responsible for UTIs.

Q: Are there known cases of resistance to Mexen building up over time?

The official product label cautions that Mexen should be used only to treat or prevent infections caused by susceptible strains of microorganisms. This instruction implicitly addresses the importance of managing the threat of bacterial resistance.

Q: Can Mexen affect blood sugar levels, especially for people with diabetes?

Amoxicillin may cause a false-positive reaction when testing for glucose (sugar) in the urine. This is an important consideration for people with diabetes who rely on this type of urine testing.

Q: Why do some infections require a higher strength of Mexen than others?

The dosage required is determined by the characteristics of the infection. Official dosage tables provide different regimens based on factors like the severity of the infection (e.g., 'Mild/Moderate' versus 'Severe') and the specific bacteria that are being targeted.

Q: Is Mexen prescribed to prevent infections, or only to treat existing ones?

According to official documentation, Mexen is indicated for both the treatment of existing infections and the prevention of infections caused by susceptible bacteria.

How should Mexen be stored and disposed of?

How to Store and Dispose of Mexen?

Strict adherence to official storage and disposal guidelines is required to maintain the medicine's integrity and ensure public safety.


Official Storage Requirements

Condition Requirement
Temperature Store at the controlled temperature specified on the official label (e.g., room temperature) unless otherwise noted.
Protection Keep the medicine in its original, tightly closed container to protect it from moisture and light.
Safety Store securely, out of the sight and reach of children and pets.

Official Disposal Instructions

Do not flush Mexen down a toilet or pour it down a drain unless the product's official label explicitly instructs this method for high-risk substances. The preferred method for disposal is to utilize a community-based drug take-back program. If no program is available, mix the medicine with an undesirable substance (such as used coffee grounds or kitty litter) and place it in a sealed bag before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Mexen found in:

A-Z Index: